Study 3, AGM vaccine dose-down study (research-grade) for "A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease"

Project: Other project

Project Details

StatusFinished
Effective start/end date11/1/19 → 2/28/21

Funding

  • Profectus BioSciences Incorporated: $115,887.00